Table 11.
No. | Compound | Source | Biological Activity |
---|---|---|---|
123 | Cnidimoside A |
Cnidium Juponicum whole plant [104,105] Cnidium monnieri fruits [60,106] |
Significant inhibition of fat accumulation at 300 μM in differentiated adipocytes [60] Antitumor and antimetastatic actions at 0.1–100 μM (in vitro) and 20, 50 mg/kg, twice daily (in vivo) [105] |
124 | Cnidimoside B |
Cnidium Juponicum whole plant [104] Cnidium monnieri fruits [60] |
Significant ihibition of fat accumulation at 300 μM in differentiated adipocytes [60] |
125 | 2-methyl-5-hydroxy-6-(2- butenyl-3-hydroxymethyl)-7-(β-d-glucopyranosyloxy)-4H- 1-benzopyran-4-one |
Cnidium monnieri fruits [60] Angelica archangelica [107] Archangelica litoralis [107] |
No reported biological activity |
126 | Hydroxycnidimoside A | Cnidium monnieri fruits [60,106] | Significant inhibition of fat accumulation at 300 μM in differentiated adipocytes [60] |
127 | Monnieriside B | Cnidium monnieri fruits [60,106] | |
128 | Monnieriside C | Cnidium monnieri fruits [60] | No reported biological activity |
129 | Monnieriside D | ||
130 | Monnieriside E | ||
131 | 7,8-Secoeranthin-β-d-glucopyranoside (8-{(2E)-4-[β-d-glucopyranosyl)oxy]-3-methylbut-2-enyl}-5,7- dihydroxy-2-methyl-4H-l-benzopyran-4-one) |
Eranthis hyemalis tubers [108] | No reported biological activity |
132 | 2-C-Hydroxy-7,8-seroeranthipn-β-d-glucopyranoside (8-{(2E)-4-[β-d-glucopyranosyl)oxy]-3-methylbut-2-enyl}-5,7- dihydroxy-2-(hydroxymethyl)-4H-1-benzopyran-4-on2) |
||
133 | 7-[(β-d-glucopyranosyl)oxy]-5-hydroxy-8-[(2E)-4-hydroxy-3-methylbut-2-enyl]-2-methyl-4H-1-benzopyran-4-one |
Eranthis cilicica tubers [109] |
No reported biological activity |
134 | 7-[(β-d-glucopyranosyl)oxy]-5-hydroxy-2-hydroxymethyl-8- [(2E)-4-hydroxy-3-methylbut-2-enyl]-4H-1-benzopyran-4-one |